case_images: PMC11036870_01
case_images: Schematic image of percentages of body parts involvement. The photos of the patients are extracted from the included articles and the reference number of the respective articles are. The photos of the patients are extracted from the included articles and the reference number of the respective articles are.
case_images: fmed-11-1293920-g002.jpg
case_images: PMC11036870_01_fmed-11-1293920-g002.jpg
case_images: fig2
case_images: Furthermore, head involvement was seen in 17% of the cases (Figure 2). The most commonly reported BP lesions are in the upper and lower limbs (77%), trunk (60%), back (11%), head and neck (17%), and mucosal area (Figure 2).
case_images: PMC11036870_02
case_images: PMC11036870_03
case_images: List of medications prescribed for disease management; the numbers are based on the most used drugs mentioned in the included articles.
case_images: fmed-11-1293920-g003.jpg
case_images: PMC11036870_03_fmed-11-1293920-g003.jpg
case_images: fig3
case_images: Furthermore, the average recovery time of the patients with the help of the above treatments is 45.15 days among the studies that reported this item (Figure 3).
case_images: PMC11036870_04
case_images: Size of body involvement based on the type of vaccine. The vertical axis represents the first, second, and third doses of the COVID-19 vaccine. The horizontal axis represents the days to cure the BP. Other parts of the horizontal axis indicate no mention of the duration of the disease cure, the continuation of the disease despite the completion of the study, or the death of the patients.
case_images: fmed-11-1293920-g004.jpg
case_images: PMC11036870_04_fmed-11-1293920-g004.jpg
case_images: fig4
case_images: In contrast, major dermal complications of inactivated vaccines developed after the third dose. mRNA vaccines were the only ones that caused large-sized dermal complications, followed by patient death (Figure 4).